Answers are grounded in this paper and cite their sources.
A prospective cohort study demonstrates effective pain relief from pericapsular nerve group neurolysis in frail hip fracture patients, highlighting a viable non-operative palliative option.
INTRODUCTION: The incidence of hip fractures is rising with the ageing population. For patients living with severe frailty and limited life expectancy, non-operative management is increasingly considered after shared decision-making. Given the limited availability of long-term analgesic options, alternative techniques are needed. Chemical neurolysis via the pericapsular nerve group block approach can selectively target sensory innervation of the hip. METHODS: A prospective multicentre cohort study was conducted at seven Dutch hospitals. Patients who chose non-operative management for a hip fracture and met the indication for neurolysis were enrolled. Patient-reported outcomes were assessed at 24 h, 1 week, 30 days and 3 months and included: quality of life; pain; analgesic use; mobility; complications; and mortality. RESULTS: We included 103 patients (mean (SD) age 87 (6.4) y); 51% were nursing home residents and 76% had cognitive impairment. The pericapsular nerve group block was performed under ultrasound guidance, with second needle placement in 14/103 (14%) patients. Mean (SD) injected volume of phenol 6% was 10 (3.1) ml. At 1 week, 34/36 (94%) patients reported acceptable pain at rest and 47/53 (89%) reported no or acceptable pain when washing and dressing. A bed-chair transfer was possible in 24/53 (45%) patients at 1 week. No procedure-related adverse events were reported. Mortality rate was 72/91 (79%) after 3 months, with a 30-day mortality of 56/91 (62%) and median (IQR [range]) survival of 9 (6-24 [0-85]) days. DISCUSSION: The pericapsular nerve group block with phenol 6% is an effective, minimally invasive procedure for pain management in addition to opioid-based pain relief in patients living with frailty, when surgery is not chosen. Procedure standardisation may improve clinical outcomes.
No takes yet. Share an insight, caveat, or question.
Smits et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: